Juha Himanen

Juha Himanen

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
DNDimitar B. Nikolov
Dimitar B. Nikolov
KXKai Xu
Kai Xu
JHJuha Himanen
Juha Himanen

4 July 2014 in Cell Adhesion & Migration
Verified
Journal Article
Closed access
DNDimitar B. Nikolov
Dimitar B. Nikolov
KXKai Xu
Kai Xu
JHJuha Himanen
Juha Himanen
The Eph receptor tyrosine kinases and their ephrin ligands direct axon pathfinding and neuronal cell migration, and mediate many other cell-cell communication events. The Ephs and ephrins both localize to the plasma membrane and, upon cell-cell contact, form extensive signaling assemblies at the contact sites. Recent structural, biochemical and cell-biological studies revealed that these assemblies are generated not only via Eph-ephrin interactions, but also via homotypic interactions between neighboring receptor molecules. In addition, Eph-Eph interactions mediate receptor pre-clustering, which ensures fast and efficient activation once ligands come into contact range. Here we summarize the current knowledge about the homotypic Eph-Eph interactions and discuss how they could modulate the initiation of Eph/ephrin signaling.

1 February 2012 in Seminars in Cell & Developmental Biology
Verified
Journal Article
Closed access
JHJuha Himanen
Juha Himanen

1 December 2023 in Science
Verified
Journal Article
Closed access
XSXiaojun Shi
Xiaojun Shi
RLRyan Lingerak
Ryan Lingerak
CHCameron J. Herting
Cameron J. Herting
YGYifan Ge
Yifan Ge
SKSoyeon Kim
Soyeon Kim
BWBingcheng Wang
Bingcheng Wang
Ephrin type-A receptor 2 (EphA2) is a receptor tyrosine kinase that initiates both ligand-dependent tumor-suppressive and ligand-independent oncogenic signaling. We used time-resolved, live-cell fluorescence spectroscopy to show that the ligand-free EphA2 assembles into multimers driven by two types of intermolecular interactions in the ectodomain. The first type entails extended symmetric interactions required for ligand-induced receptor clustering and tumor-suppressive signaling that inhibits activity of the oncogenic extracellular signal–regulated kinase (ERK) and protein kinase B (AKT) protein kinases and suppresses cell migration. The second type is an asymmetric interaction between the amino terminus and the membrane proximal domain of the neighboring receptors, which supports oncogenic signaling and promotes migration in vitro and tumor invasiveness in vivo. Our results identify the molecular interactions that drive the formation of the EphA2 multimeric signaling clusters and reveal the pivotal role of EphA2 assembly in dictating its opposing functions in oncogenesis.

1 December 2018 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
NSNayanendu Saha
Nayanendu Saha
DRDorothea Robev
Dorothea Robev
EMEmilia O. Mason
Emilia O. Mason
JHJuha Himanen
Juha Himanen
DNDimitar B. Nikolov
Dimitar B. Nikolov

1 September 2010 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
NSNikhil Singla
Nikhil Singla
YGYehuda Goldgur
Yehuda Goldgur
KXKai Xu
Kai Xu
SPSari Paavilainen
Sari Paavilainen
DNDimitar B. Nikolov
Dimitar B. Nikolov
JHJuha Himanen
Juha Himanen